StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
118
This month
1
This year
15
Publishing Date
2024 - 03 - 13
2
2024 - 01 - 17
2
2023 - 10 - 30
2
2023 - 07 - 05
2
2023 - 03 - 02
2
2023 - 02 - 24
4
2023 - 02 - 09
1
2023 - 02 - 02
1
2023 - 01 - 31
1
2023 - 01 - 27
1
2023 - 01 - 18
1
2023 - 01 - 11
1
2023 - 01 - 09
1
2023 - 01 - 04
1
2022 - 12 - 27
1
2022 - 12 - 15
1
2022 - 12 - 13
1
2022 - 12 - 12
1
2022 - 12 - 02
1
2022 - 11 - 28
1
2022 - 11 - 22
1
2022 - 11 - 17
1
2022 - 11 - 10
2
2022 - 11 - 08
1
2022 - 11 - 03
1
2022 - 11 - 02
1
2022 - 10 - 14
1
2022 - 09 - 06
1
2022 - 08 - 29
1
2022 - 08 - 23
1
2022 - 08 - 17
1
2022 - 07 - 28
1
2022 - 07 - 21
1
2022 - 06 - 29
1
2022 - 06 - 23
1
2022 - 06 - 21
1
2022 - 06 - 20
1
2022 - 06 - 13
2
2022 - 05 - 30
1
2022 - 05 - 16
1
2022 - 05 - 09
1
2022 - 04 - 26
1
2022 - 04 - 21
1
2022 - 03 - 31
1
2022 - 03 - 23
1
2022 - 03 - 21
1
2022 - 03 - 17
1
2022 - 02 - 28
1
2022 - 02 - 14
1
2022 - 02 - 09
1
2022 - 02 - 01
2
2021 - 12 - 31
1
2021 - 12 - 24
1
2021 - 12 - 20
1
2021 - 12 - 17
1
2021 - 11 - 02
1
2021 - 10 - 28
1
2021 - 10 - 18
1
2021 - 10 - 13
2
2021 - 10 - 07
1
Sector
Commercial services
1
Communications
6
Distribution services
2
Electronic technology
3
Health services
4
Health technology
118
Information
1
Manufacturing
15
N/a
7
Process industries
1
Producer manufacturing
1
Professional, scientific, and technical services
2
Technology services
2
Tags
Agreement
8
Alzheimer's
10
America
67
Antibody
8
Approval
13
Biosimilar
32
Breast
13
Business
9
Cancer
91
Cell
9
Chmp
10
Diabetes
15
Diagnostics
17
Disease
61
Drug
86
Earnings
18
Europe
15
Expansion
11
Expected
35
Eye
15
Fda
23
Financial
24
Global
228
Growing
43
Growth
236
Health
19
Immunotherapy
11
Infection
9
Key
9
Kisqali
11
Leukemia
10
Liver
11
Market
593
N/a
949
Novartis
135
People
13
Pharma
13
Pharmaceuticals
17
Pipeline
12
Positive
16
Potential
10
Reach
34
Report
194
Research
118
Respiratory
11
Results
38
Risk
10
Sales
10
Sclerosis
13
Set
16
Study
15
T-cell
11
Technology
12
Therapeutics
110
Therapy
65
Treatment
114
Trial
16
Update
10
Vaccine
10
Year
12
Entities
Abbott laboratories
10
Abbvie inc.
25
Abcam plc
1
Abeona therapeutics inc.
1
Adaptimmune therapeutics plc
3
Aerie pharmaceuticals, inc.
1
Agilent technologies, inc.
1
Alkermes plc
1
American cryostem corp
1
Amgen inc.
13
Amicus therapeutics, inc.
1
Amneal pharmaceuticals, inc.
1
Amphastar pharmaceuticals, inc.
1
Ani pharmaceuticals, inc.
1
Apple inc.
1
Applied genetic technologies corporation
1
Astellas pharma inc
9
Astrazeneca plc
21
Atara biotherapeutics, inc.
1
Athenex, inc.
1
Bausch health companies inc.
8
Baxter international inc.
4
Becton, dickinson and company
2
Beigene, ltd.
1
Bio-rad laboratories, inc.
2
Biofrontera ag
1
Biogen inc.
6
Biontech se
1
Bluebird bio, inc.
1
Boston scientific corporation
1
Brainstorm cell therapeutics inc.
1
Bristol-myers squibb company
16
Cannabis sativa, inc.
1
Cardinal health, inc.
2
Celldex therapeutics, inc.
1
Eli lilly and company
20
Gilead sciences, inc.
3
Glaxosmithkline plc
30
Grifols sa
2
Hologic, inc.
2
Inovio pharmaceuticals, inc.
2
Ionis pharmaceuticals, inc.
2
Johnson & johnson
28
Jsr corp.
2
Koninklijke philips n.v.
4
Mallinckrodt plc
2
Medtronic plc
6
Novartis ag
118
Novo nordisk a/s
2
Orange
6
Pfizer, inc.
9
Sanofi
38
Sarepta therapeutics, inc.
2
Stryker corporation
2
Takeda pharmaceutical company limited
7
Teva pharmaceutical industries limited
2
Teva pharmaceutical industries ltd
20
Thermo fisher scientific inc
5
Verona pharma plc
2
Viatris inc.
15
Symbols
A
79
AAPL
89
ABB
165
ABBV
81
ABLZF
130
ABT
195
ACMR
59
ARVL
54
AZN
73
BDX
101
BIO
93
BMY
80
BSX
66
CSCO
155
DHR
128
DNZOF
55
DNZOY
55
EMN
52
ERIC
118
FNCTF
746
GE
113
GILD
54
GLAXF
76
GOOG
57
GOOGL
57
GSK
88
HON
214
IBM
83
IFNNF
61
IFNNY
58
ILMN
59
INTC
136
JNJ
318
LLY
148
LMT
78
LRCX
56
MDT
132
MMM
99
MSFT
225
NIPNF
65
NOC
62
NVDA
56
NVS
129
NVSEF
118
ORCL
192
PCRFF
61
PCRFY
61
PFE
51
PHG
120
PKI
53
QGEN
62
RTX
53
SAP
181
SAPGF
160
SNY
266
SNYNF
234
SYK
72
TEVJF
59
TMO
257
XOM
52
Exchanges
Nasdaq
118
Nyse
118
Crawled Date
2024 - 03 - 13
2
2024 - 01 - 17
2
2023 - 12 - 15
2
2023 - 10 - 30
2
2023 - 03 - 02
2
2023 - 02 - 24
4
2023 - 02 - 09
1
2023 - 02 - 02
1
2023 - 01 - 31
1
2023 - 01 - 27
1
2023 - 01 - 18
1
2023 - 01 - 11
1
2023 - 01 - 09
1
2023 - 01 - 04
1
2022 - 12 - 27
1
2022 - 12 - 15
1
2022 - 12 - 13
1
2022 - 12 - 12
1
2022 - 12 - 02
1
2022 - 11 - 28
1
2022 - 11 - 22
1
2022 - 11 - 17
1
2022 - 11 - 10
2
2022 - 11 - 08
1
2022 - 11 - 03
1
2022 - 11 - 02
1
2022 - 10 - 14
1
2022 - 09 - 06
1
2022 - 08 - 29
1
2022 - 08 - 23
1
2022 - 08 - 17
1
2022 - 07 - 28
1
2022 - 07 - 21
1
2022 - 06 - 29
1
2022 - 06 - 23
1
2022 - 06 - 21
1
2022 - 06 - 20
1
2022 - 06 - 13
2
2022 - 05 - 30
1
2022 - 05 - 16
1
2022 - 05 - 09
1
2022 - 04 - 26
1
2022 - 04 - 21
1
2022 - 03 - 31
1
2022 - 03 - 23
1
2022 - 03 - 21
1
2022 - 03 - 17
1
2022 - 02 - 28
1
2022 - 02 - 14
1
2022 - 02 - 09
1
2022 - 02 - 01
2
2021 - 12 - 31
1
2021 - 12 - 24
1
2021 - 12 - 20
1
2021 - 12 - 17
1
2021 - 11 - 02
1
2021 - 10 - 28
1
2021 - 10 - 18
1
2021 - 10 - 13
2
2021 - 10 - 07
1
Crawled Time
00:00
3
01:00
7
02:00
3
03:00
3
04:00
1
04:20
1
05:00
2
07:00
2
08:00
2
08:20
1
09:00
12
10:00
4
11:00
6
12:00
8
12:20
2
12:30
2
13:00
4
13:15
1
13:20
2
14:00
9
14:20
3
14:30
3
15:00
6
15:20
1
15:30
4
16:00
5
17:00
5
18:00
7
19:00
3
20:00
3
22:00
2
23:00
1
Source
www.biospace.com
7
www.globenewswire.com
2
www.prnewswire.com
109
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
tags :
Research
symbols :
NVSEF
save search
Emphysema Treatment Market to Reach $8.7 Billion, Globally, by 2032 at 3.3% CAGR: Allied Market Research
Published:
2024-04-16
(Crawled : 14:00)
- prnewswire.com
VTRS
|
News
A
|
$11.55
1.67%
1.65%
4.4M
|
Health Technology
|
2.03%
|
O:
-0.53%
H:
0.0%
C:
-1.24%
NVS
|
News
|
$98.35
1.1%
0.69%
2.1M
|
Health Technology
|
4.41%
|
O:
-1.46%
H:
0.0%
C:
0.0%
PHG
|
News
|
$20.97
-0.19%
0.0%
650K
|
Health Technology
|
1.45%
|
O:
-1.21%
H:
0.0%
C:
0.0%
GSK
|
News
|
$40.86
-0.92%
1.25%
1.6M
|
Health Technology
|
0.89%
|
O:
-1.19%
H:
0.52%
C:
-0.17%
VRNA
|
$15.24
-2.25%
-2.5%
320K
|
Health Technology
|
-0.57%
|
O:
1.65%
H:
2.43%
C:
0.87%
reach
treatment
research
market
Global Acute Lymphoblastic Leukemia Therapeutics Market Research 2024-2033: Developments Review, Regulatory Landscape, Competitive Benchmarking, Dynamic Landscape
Published:
2024-03-29
(Crawled : 18:00)
- prnewswire.com
BMY
|
$48.86
-0.27%
0.98%
14M
|
Health Technology
|
Email alert
Add to watchlist
GILD
|
$67.08
0.08%
0.06%
6.2M
|
Health Technology
|
Email alert
Add to watchlist
SNYNF
|
News
|
$94.0
-0.27%
-2.18%
310
|
Health Technology
|
Email alert
Add to watchlist
AMGN
|
News
|
$273.01
-0.19%
-0.17%
1.5M
|
Health Technology
|
Email alert
Add to watchlist
GMAB
|
News
|
$28.47
-0.32%
-0.32%
430K
|
Health Technology
|
Email alert
Add to watchlist
SNY
|
News
|
$46.61
-2.27%
-2.21%
1.6M
|
Health Technology
|
Email alert
Add to watchlist
NVSEF
|
News
|
$96.0
0.94%
6.88%
0
|
Health Technology
|
Email alert
Add to watchlist
NVS
|
News
|
$98.35
1.1%
0.69%
2.1M
|
Health Technology
|
Email alert
Add to watchlist
GNMSF
|
News
|
$290.34
0.23%
3.83%
1.2K
|
Health Technology
|
Email alert
Add to watchlist
ABBV
|
News
|
$167.8
-1.03%
-0.02%
2.9M
|
Health Technology
|
Email alert
Add to watchlist
research
global
leukemia
therapeutics
market
Global Antibody Therapeutic Industry Research 2023-2024 & 2033: Exploring the Expanding Role in Managing Cancer, Autoimmune Disorders, and Infectious Diseases
Published:
2024-03-28
(Crawled : 15:30)
- prnewswire.com
GLAXF
|
News
|
$19.54
-3.77%
-14.18%
170
|
Health Technology
|
-6.37%
|
O:
0.99%
H:
0.0%
C:
0.0%
NVSEF
|
News
|
$96.0
0.94%
6.88%
0
|
Health Technology
|
0.33%
|
O:
-100.0%
H:
NaN%
C:
Infinity%
NVS
|
News
|
$98.35
1.1%
0.69%
2.1M
|
Health Technology
|
2.58%
|
O:
0.52%
H:
0.0%
C:
0.0%
JNJ
|
News
|
$148.53
-0.69%
0.18%
7.5M
|
Health Technology
|
-5.1%
|
O:
1.32%
H:
0.0%
C:
0.0%
GSK
|
News
|
$40.86
-0.92%
1.25%
1.6M
|
Health Technology
|
-4.95%
|
O:
0.02%
H:
0.51%
C:
-0.3%
LLY
|
News
|
$732.2
-1.81%
-0.84%
1.7M
|
Health Technology
|
-3.34%
|
O:
0.28%
H:
1.71%
C:
-0.3%
BMY
|
$48.86
-0.27%
0.98%
14M
|
Health Technology
|
-8.24%
|
O:
0.26%
H:
2.03%
C:
1.57%
AMGN
|
News
|
$273.01
-0.19%
-0.17%
1.5M
|
Health Technology
|
-4.64%
|
O:
0.54%
H:
0.0%
C:
0.0%
antibody
research
global
Global Irritable Bowel Disease (IBD) Market Research Report 2024: Corticosteroids, JAK inhibitors, TNF inhibitors, Other Drug Classes Insights and Forecast 2019-2029
Published:
2024-03-13
(Crawled : 03:00)
- prnewswire.com
NVSEF
|
News
|
$96.0
0.94%
6.88%
0
|
Health Technology
|
-2.36%
|
O:
-0.23%
H:
0.0%
C:
0.0%
NVS
|
News
|
$98.35
1.1%
0.69%
2.1M
|
Health Technology
|
-1.42%
|
O:
-0.07%
H:
0.09%
C:
-0.7%
JNJ
|
News
|
$148.53
-0.69%
0.18%
7.5M
|
Health Technology
|
-8.22%
|
O:
0.66%
H:
0.0%
C:
0.0%
LLY
|
News
|
$732.2
-1.81%
-0.84%
1.7M
|
Health Technology
|
-0.36%
|
O:
0.27%
H:
0.5%
C:
0.11%
ABBV
|
News
|
$167.8
-1.03%
-0.02%
2.9M
|
Health Technology
|
-7.51%
|
O:
0.59%
H:
0.01%
C:
-1.45%
drug
disease
report
research
global
market
Global IgG Mediated Autoimmune Diseases Biologic Drugs Research Report 2023-2029: Shift Towards Personalized Medicine and Targeted Therapies & Adoption of Biosimilars and Biobetters
Published:
2024-03-13
(Crawled : 01:00)
- prnewswire.com
NVSEF
|
News
|
$96.0
0.94%
6.88%
0
|
Health Technology
|
-2.36%
|
O:
-0.23%
H:
0.0%
C:
0.0%
NVS
|
News
|
$98.35
1.1%
0.69%
2.1M
|
Health Technology
|
-1.42%
|
O:
-0.07%
H:
0.09%
C:
-0.7%
JNJ
|
News
|
$148.53
-0.69%
0.18%
7.5M
|
Health Technology
|
-8.22%
|
O:
0.66%
H:
0.0%
C:
0.0%
LLY
|
News
|
$732.2
-1.81%
-0.84%
1.7M
|
Health Technology
|
-0.36%
|
O:
0.27%
H:
0.5%
C:
0.11%
ABBV
|
News
|
$167.8
-1.03%
-0.02%
2.9M
|
Health Technology
|
-7.51%
|
O:
0.59%
H:
0.01%
C:
-1.45%
SNY
|
News
|
$46.61
-2.27%
-2.21%
1.6M
|
Health Technology
|
-1.85%
|
O:
-0.04%
H:
0.0%
C:
0.0%
report
research
global
Global Incretin Based Drugs Research Report 2023: Market to Reach $64.28 Billion by 2029 from $40 Billion in 2022, Driven by Increasing Prevalence of Diabetes
Published:
2024-02-21
(Crawled : 02:00)
- prnewswire.com
AZNCF
|
News
|
$135.35
-3.53%
-4.19%
400
|
Health Technology
|
5.33%
|
O:
-0.88%
H:
1.75%
C:
-0.29%
NVS
|
News
|
$98.35
1.1%
0.69%
2.1M
|
Health Technology
|
-4.25%
|
O:
-0.65%
H:
0.62%
C:
0.5%
LLY
|
News
|
$732.2
-1.81%
-0.84%
1.7M
|
Health Technology
|
-0.46%
|
O:
-2.33%
H:
1.55%
C:
1.06%
AZN
|
News
|
$71.2
0.49%
0.46%
5.4M
|
Health Technology
|
9.47%
|
O:
-1.01%
H:
1.1%
C:
1.1%
report
reach
research
global
diabetes
market
Orphan Drugs Market Projection: BCC Research Anticipates a Staggering $415.2 Billion Valuation by 2028, Reflecting Soaring Global Demand
Published:
2024-02-09
(Crawled : 10:00)
- prnewswire.com
ALPMF
|
News
|
$9.5
-2.56%
43.47%
21K
|
Health Technology
|
-13.24%
|
O:
-0.91%
H:
3.88%
C:
3.88%
AZNCF
|
News
|
$135.35
-3.53%
-4.19%
400
|
Health Technology
|
8.28%
|
O:
-2.6%
H:
2.26%
C:
1.44%
NVSEF
|
News
|
$96.0
0.94%
6.88%
0
|
Health Technology
|
-7.06%
|
O:
-2.46%
H:
0.0%
C:
0.0%
ALPMY
|
News
|
$9.47
-0.21%
-1.11%
400K
|
Manufacturing
|
-11.74%
|
O:
4.66%
H:
0.0%
C:
-3.92%
PFE
|
News
4
|
$26.27
-0.19%
0.19%
18M
|
Health Technology
|
-4.72%
|
O:
-0.04%
H:
0.11%
C:
0.0%
NVS
|
News
|
$98.35
1.1%
0.69%
2.1M
|
Health Technology
|
-2.97%
|
O:
-0.37%
H:
0.21%
C:
0.05%
ABBV
|
News
|
$167.8
-1.03%
-0.02%
2.9M
|
Health Technology
|
-3.8%
|
O:
0.33%
H:
0.0%
C:
0.0%
SNY
|
News
|
$46.61
-2.27%
-2.21%
1.6M
|
Health Technology
|
2.94%
|
O:
1.11%
H:
0.0%
C:
0.0%
AZN
|
News
|
$71.2
0.49%
0.46%
5.4M
|
Health Technology
|
12.09%
|
O:
-1.28%
H:
1.05%
C:
-0.72%
research
global
market
United States Endometrial Cancer Research Report 2023
Published:
2024-02-02
(Crawled : 10:00)
- prnewswire.com
TAK
|
News
|
$13.23
-1.12%
0.0%
920K
|
Health Technology
|
-8.0%
|
O:
0.21%
H:
0.49%
C:
-0.9%
NVS
|
News
|
$98.35
1.1%
0.69%
2.1M
|
Health Technology
|
-6.63%
|
O:
-0.5%
H:
0.26%
C:
-1.03%
report
cancer
research
Vertigo Drugs Market Research Report 2023 - Global Industry Size, Share, Trends, Opportunity, and Forecasts, 2018-2028F
Published:
2024-02-01
(Crawled : 18:00)
- prnewswire.com
ENDPQ
|
News
|
$0.0007
-50.0%
1K
|
n/a
|
566.67%
|
O:
-83.33%
H:
500.0%
C:
500.0%
GLAXF
|
News
|
$19.54
-3.77%
-14.18%
170
|
Health Technology
|
-0.75%
|
O:
-0.7%
H:
0.0%
C:
0.0%
NVS
|
News
|
$98.35
1.1%
0.69%
2.1M
|
Health Technology
|
-6.63%
|
O:
-0.5%
H:
0.26%
C:
-1.03%
GSK
|
News
|
$40.86
-0.92%
1.25%
1.6M
|
Health Technology
|
0.57%
|
O:
-0.05%
H:
0.59%
C:
0.27%
report
research
global
market
USD 10.40 billion growth in Vascular Endothelial Market between 2022 and 2027, The strategic alliances and collaborations are notably driving market growth-17,000+ Technavio Research Reports
Published:
2024-01-22
(Crawled : 05:00)
- prnewswire.com
SNYNF
|
News
|
$94.0
-0.27%
-2.18%
310
|
Health Technology
|
-7.4%
|
O:
1.71%
H:
0.0%
C:
-0.15%
AZNCF
|
News
|
$135.35
-3.53%
-4.19%
400
|
Health Technology
|
2.69%
|
O:
2.63%
H:
0.8%
C:
0.75%
NVSEF
|
News
|
$96.0
0.94%
6.88%
0
|
Health Technology
|
-10.28%
|
O:
1.4%
H:
0.0%
C:
0.0%
VTRS
|
News
A
|
$11.55
1.67%
1.65%
4.4M
|
Health Technology
|
1.32%
|
O:
-0.18%
H:
2.37%
C:
2.28%
NVS
|
News
|
$98.35
1.1%
0.69%
2.1M
|
Health Technology
|
-9.13%
|
O:
0.12%
H:
0.39%
C:
0.1%
ABBV
|
News
|
$167.8
-1.03%
-0.02%
2.9M
|
Health Technology
|
2.81%
|
O:
0.57%
H:
0.0%
C:
0.0%
SNY
|
News
|
$46.61
-2.27%
-2.21%
1.6M
|
Health Technology
|
-7.41%
|
O:
-0.21%
H:
0.0%
C:
0.0%
AZN
|
News
|
$71.2
0.49%
0.46%
5.4M
|
Health Technology
|
7.0%
|
O:
1.8%
H:
0.14%
C:
-0.89%
AMGN
|
News
|
$273.01
-0.19%
-0.17%
1.5M
|
Health Technology
|
-11.31%
|
O:
0.29%
H:
1.12%
C:
0.47%
research
growth
market
Global Orphan Drugs Market Research Report 2023: Market to Reach $415.2 Billion by the End of 2028 - Premium Pricing of Orphan Drugs and Increasing Collaborations/Licensing Agreements Bolsters Growth
Published:
2024-01-17
(Crawled : 20:00)
- prnewswire.com
SNYNF
|
News
|
$94.0
-0.27%
-2.18%
310
|
Health Technology
|
-7.84%
|
O:
0.1%
H:
0.76%
C:
0.76%
AZNCF
|
News
|
$135.35
-3.53%
-4.19%
400
|
Health Technology
|
1.01%
|
O:
1.06%
H:
0.0%
C:
-2.34%
NVSEF
|
News
|
$96.0
0.94%
6.88%
0
|
Health Technology
|
-10.45%
|
O:
0.0%
H:
0.0%
C:
0.0%
ALPMY
|
News
|
$9.47
-0.21%
-1.11%
400K
|
Manufacturing
|
-19.27%
|
O:
-0.6%
H:
0.34%
C:
0.34%
NVS
|
News
|
$98.35
1.1%
0.69%
2.1M
|
Health Technology
|
-9.15%
|
O:
-0.78%
H:
0.59%
C:
0.57%
JNJ
|
News
|
$148.53
-0.69%
0.18%
7.5M
|
Health Technology
|
-7.57%
|
O:
-0.21%
H:
0.0%
C:
0.0%
ABBV
|
News
|
$167.8
-1.03%
-0.02%
2.9M
|
Health Technology
|
3.55%
|
O:
-0.54%
H:
1.55%
C:
1.33%
SNY
|
News
|
$46.61
-2.27%
-2.21%
1.6M
|
Health Technology
|
-8.12%
|
O:
-1.1%
H:
1.63%
C:
1.59%
AZN
|
News
|
$71.2
0.49%
0.46%
5.4M
|
Health Technology
|
7.47%
|
O:
-0.51%
H:
1.33%
C:
0.93%
report
reach
research
global
growth
market
2023 Inhalers Pipeline Research Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies
Published:
2024-01-17
(Crawled : 18:00)
- prnewswire.com
NVSEF
|
News
|
$96.0
0.94%
6.88%
0
|
Health Technology
|
-10.45%
|
O:
0.0%
H:
0.0%
C:
0.0%
NVS
|
News
|
$98.35
1.1%
0.69%
2.1M
|
Health Technology
|
-9.15%
|
O:
-0.78%
H:
0.59%
C:
0.57%
VRNA
|
$15.24
-2.25%
-2.5%
320K
|
Health Technology
|
-8.87%
|
O:
0.52%
H:
2.31%
C:
-0.87%
NKTR
|
News
|
$1.38
-2.82%
-2.16%
960K
|
Health Technology
|
179.58%
|
O:
-0.73%
H:
12.24%
C:
12.24%
companies
report
pipeline
research
key
Global Antibody Fragments Market Research Report 2023: Market to Reach $9.6 Billion by 2028 - Increasing Investments in Biopharmaceuticals Driving Growth
Published:
2024-01-15
(Crawled : 20:00)
- prnewswire.com
SNYNF
|
News
|
$94.0
-0.27%
-2.18%
310
|
Health Technology
|
-11.32%
|
O:
-2.03%
H:
0.05%
C:
0.05%
NVS
|
News
|
$98.35
1.1%
0.69%
2.1M
|
Health Technology
|
-8.47%
|
O:
0.16%
H:
0.43%
C:
0.07%
LLY
|
News
|
$732.2
-1.81%
-0.84%
1.7M
|
Health Technology
|
17.0%
|
O:
0.15%
H:
0.59%
C:
-1.45%
ABBV
|
News
|
$167.8
-1.03%
-0.02%
2.9M
|
Health Technology
|
3.08%
|
O:
-0.49%
H:
0.0%
C:
0.0%
SNY
|
News
|
$46.61
-2.27%
-2.21%
1.6M
|
Health Technology
|
-9.4%
|
O:
-1.34%
H:
0.0%
C:
0.0%
investments
report
antibody
reach
research
global
growth
market
Advancing Melanoma Therapeutics: Global Market Insights and In-depth Analysis by BCC Research
Published:
2024-01-12
(Crawled : 11:00)
- prnewswire.com
AZNCF
|
News
|
$135.35
-3.53%
-4.19%
400
|
Health Technology
|
-1.22%
|
O:
2.07%
H:
0.0%
C:
-0.06%
ERAS
|
$1.88
-2.59%
-2.66%
530K
|
|
-3.59%
|
O:
0.0%
H:
4.62%
C:
-1.03%
NVS
|
News
|
$98.35
1.1%
0.69%
2.1M
|
Health Technology
|
-8.6%
|
O:
-0.16%
H:
0.43%
C:
0.02%
AZN
|
News
|
$71.2
0.49%
0.46%
5.4M
|
Health Technology
|
2.92%
|
O:
0.25%
H:
0.36%
C:
0.1%
AMGN
|
News
|
$273.01
-0.19%
-0.17%
1.5M
|
Health Technology
|
-9.93%
|
O:
0.71%
H:
0.56%
C:
0.42%
melanoma
research
global
market
Global Cystic Fibrosis Lung Disease Research Report 2023: Analysis and Forecasts by Drug Type, Route of Administration, Distribution Channel, Region, and Country 2019-2029
Published:
2024-01-09
(Crawled : 17:00)
- prnewswire.com
NVSEF
|
News
|
$96.0
0.94%
6.88%
0
|
Health Technology
|
-9.65%
|
O:
-0.24%
H:
0.0%
C:
0.0%
NVS
|
News
|
$98.35
1.1%
0.69%
2.1M
|
Health Technology
|
-8.15%
|
O:
-0.46%
H:
0.74%
C:
-0.19%
lung
drug
disease
report
distribution
fibrosis
research
global
Incretin-based Drugs Market to Reach $73.9 billion, globally, by 2032 at 7.9% CAGR: Allied Market Research
Published:
2023-12-15
(Crawled : 15:30)
- prnewswire.com
AZNCF
|
News
|
$135.35
-3.53%
-4.19%
400
|
Health Technology
|
2.15%
|
O:
-3.0%
H:
2.15%
C:
2.15%
NVSEF
|
News
|
$96.0
0.94%
6.88%
0
|
Health Technology
|
-2.04%
|
O:
0.0%
H:
0.0%
C:
0.0%
NVO
|
News
|
$126.16
-1.93%
-2.24%
3M
|
Health Technology
|
28.73%
|
O:
-0.48%
H:
0.0%
C:
-0.44%
NVS
|
News
|
$98.35
1.1%
0.69%
2.1M
|
Health Technology
|
-0.53%
|
O:
-1.31%
H:
0.56%
C:
-0.17%
LLY
|
News
|
$732.2
-1.81%
-0.84%
1.7M
|
Health Technology
|
26.71%
|
O:
-4.44%
H:
0.0%
C:
0.0%
SNY
|
News
|
$46.61
-2.27%
-2.21%
1.6M
|
Health Technology
|
-1.77%
|
O:
-0.93%
H:
0.0%
C:
0.0%
AZN
|
News
|
$71.2
0.49%
0.46%
5.4M
|
Health Technology
|
7.31%
|
O:
-2.23%
H:
0.28%
C:
-0.11%
reach
research
market
Global Fog Computing Market Research Report 2023-2028 - Emerging Trend of Connected and Modern Vehicles Driving Adoption
Published:
2023-12-14
(Crawled : 00:00)
- prnewswire.com
SNNUF
|
$11.66
-5.89%
-1.12%
470
|
Health Technology
|
-16.12%
|
O:
-2.95%
H:
0.0%
C:
-1.59%
TRUMF
|
$16.79
1.1%
-17.59%
840
|
Health Technology
|
-49.29%
|
O:
-2.68%
H:
3.46%
C:
3.25%
GLAXF
|
News
|
$19.54
-3.77%
-14.18%
170
|
Health Technology
|
8.83%
|
O:
-1.81%
H:
0.0%
C:
-1.79%
NVSEF
|
News
|
$96.0
0.94%
6.88%
0
|
Health Technology
|
-2.04%
|
O:
0.0%
H:
0.0%
C:
0.0%
TRUMY
|
$17.09
0.24%
0.79%
30K
|
Manufacturing
|
-48.26%
|
O:
-1.27%
H:
0.0%
C:
-0.46%
SYK
|
$336.85
0.58%
0.93%
1.2M
|
Health Technology
|
13.38%
|
O:
-3.68%
H:
2.11%
C:
1.39%
NVS
|
News
|
$98.35
1.1%
0.69%
2.1M
|
Health Technology
|
-0.53%
|
O:
-1.31%
H:
0.56%
C:
-0.17%
MDT
|
$80.38
-1.12%
-0.03%
5M
|
Health Technology
|
-3.66%
|
O:
-0.42%
H:
0.25%
C:
-0.57%
JNJ
|
News
|
$148.53
-0.69%
0.18%
7.5M
|
Health Technology
|
-5.36%
|
O:
-0.39%
H:
0.0%
C:
0.0%
GSK
|
News
|
$40.86
-0.92%
1.25%
1.6M
|
Health Technology
|
10.49%
|
O:
-1.84%
H:
0.3%
C:
-1.16%
BSX
|
$72.91
5.68%
0.0%
13M
|
Health Technology
|
29.78%
|
O:
-0.69%
H:
0.45%
C:
0.04%
BAX
|
$40.93
-0.22%
0.0%
2.2M
|
Health Technology
|
5.08%
|
O:
-0.51%
H:
1.08%
C:
-0.13%
ABT
|
News
|
$106.89
-0.65%
0.07%
4.2M
|
Health Technology
|
-0.87%
|
O:
-0.25%
H:
0.0%
C:
0.0%
vehicles
report
research
global
market
Parkinson's Disease Therapeutics Market revenue to hit USD 12.32 Billion by 2033, Says We Market Research
Published:
2023-12-06
(Crawled : 15:30)
- prnewswire.com
GLAXF
|
News
|
$19.54
-3.77%
-14.18%
170
|
Health Technology
|
12.08%
|
O:
1.64%
H:
0.0%
C:
-1.33%
NVS
|
News
|
$98.35
1.1%
0.69%
2.1M
|
Health Technology
|
1.42%
|
O:
0.52%
H:
0.18%
C:
-0.43%
GSK
|
News
|
$40.86
-0.92%
1.25%
1.6M
|
Health Technology
|
12.47%
|
O:
-0.03%
H:
0.28%
C:
-0.41%
LLY
|
News
|
$732.2
-1.81%
-0.84%
1.7M
|
Health Technology
|
29.05%
|
O:
0.99%
H:
0.0%
C:
0.0%
ABBV
|
News
|
$167.8
-1.03%
-0.02%
2.9M
|
Health Technology
|
16.07%
|
O:
0.26%
H:
0.0%
C:
0.0%
DNLI
|
$15.56
-3.41%
-3.6%
940K
|
Health Technology
|
-16.07%
|
O:
0.05%
H:
5.74%
C:
3.18%
BIIB
|
$201.99
4.56%
4.32%
2.7M
|
Health Technology
|
-12.01%
|
O:
0.42%
H:
2.37%
C:
1.45%
disease
parkinson's
revenue
research
therapeutics
market
Gene therapy market size to grow by USD 4,613.9 million from 2022 to 2027 | Growing research in gene therapy for CVDs and orphan diseases is the major market trend- Technavio
Published:
2023-12-01
(Crawled : 08:00)
- prnewswire.com
ALPMF
|
News
|
$9.5
-2.56%
43.47%
21K
|
Health Technology
|
-19.29%
|
O:
3.87%
H:
0.0%
C:
0.0%
NVSEF
|
News
|
$96.0
0.94%
6.88%
0
|
Health Technology
|
-0.54%
|
O:
1.48%
H:
0.0%
C:
0.0%
ALPMY
|
News
|
$9.47
-0.21%
-1.11%
400K
|
Manufacturing
|
-22.12%
|
O:
-3.37%
H:
4.51%
C:
4.51%
NVS
|
News
|
$98.35
1.1%
0.69%
2.1M
|
Health Technology
|
0.46%
|
O:
-0.25%
H:
0.68%
C:
0.48%
ORTX
|
$16.7
0.0%
370K
|
Health Technology
|
2.53%
|
O:
-0.09%
H:
0.0%
C:
0.0%
GBIO
|
News
|
$2.99
-8.28%
-8.85%
110K
|
Health Technology
|
164.6%
|
O:
0.0%
H:
38.05%
C:
23.01%
BIIB
|
$201.99
4.56%
4.32%
2.7M
|
Health Technology
|
-13.71%
|
O:
-0.06%
H:
0.35%
C:
0.29%
AMGN
|
News
|
$273.01
-0.19%
-0.17%
1.5M
|
Health Technology
|
1.25%
|
O:
0.12%
H:
0.97%
C:
0.92%
ADAP
|
$1.08
-5.26%
-5.07%
790K
|
Health Technology
|
116.0%
|
O:
-5.76%
H:
16.36%
C:
15.07%
ABEO
|
News
|
$3.17
-7.04%
-7.74%
2.1M
|
Health Technology
|
-35.83%
|
O:
-2.43%
H:
0.0%
C:
0.0%
research
growing
therapy
market
Rabies Vaccine Market to Reach $ 1903.17 million by 2032, exhibiting a CAGR of 4.7% from 2023 to 2032: Allied Market Research
Published:
2023-11-25
(Crawled : 08:20)
- prnewswire.com
SNY
|
News
|
$46.61
-2.27%
-2.21%
1.6M
|
Health Technology
|
Email alert
Add to watchlist
ELAN
|
$13.31
-1.11%
0.0%
3.8M
|
Process Industries
|
Email alert
Add to watchlist
SNYNF
|
News
|
$94.0
-0.27%
-2.18%
310
|
Health Technology
|
Email alert
Add to watchlist
NVS
|
News
|
$98.35
1.1%
0.69%
2.1M
|
Health Technology
|
Email alert
Add to watchlist
NVSEF
|
News
|
$96.0
0.94%
6.88%
0
|
Health Technology
|
Email alert
Add to watchlist
ZTS
|
$150.88
0.88%
0.68%
3.2M
|
Health Technology
|
Email alert
Add to watchlist
FNCTF
|
News
|
$11.16
1.13%
-20.84%
0
|
Communications
|
Email alert
Add to watchlist
vaccine
reach
research
market
← Previous
1
2
3
4
5
6
Next →
Gainers vs Losers
62%
38%
Top 10 Gainers
CSSE
4
|
$0.4253
179.25%
64.77%
210M
|
Consumer Services
BOF
|
$2.08
77.78%
41.21%
110M
|
ILAG
|
$0.54
12.27%
40.62%
3.7M
|
LICN
|
$0.999
78.39%
40.49%
15M
|
AMST
|
$3.4
70.0%
39.58%
70M
|
Technology Services
MTC
|
$3.6
60.71%
38.04%
9.1M
|
Technology Services
WIMI
|
$1.15
58.53%
36.92%
19M
|
Technology Services
AIH
|
$0.458
14.5%
30.92%
91K
|
Health Services
WHLM
|
$6.25
35.87%
28.46%
700K
|
Commercial Services
MULN
|
News
|
$3.77
38.1%
27.78%
13M
|
Information
Your saved searches
Save your searches and get alerts when important news are released.